Literature DB >> 15380932

Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans.

Rafael de la Torre1, Magí Farré.   

Abstract

Several studies suggest that MDMA-induced acute toxicity and long-term neurotoxicity is dependent on the metabolic disposition of MDMA. Differences in MDMA metabolism among animal species might therefore account for different sensitivities to its neurotoxic effects. The kinetic parameters of enzymes that regulate the formation of neurotoxic metabolites of MDMA differ among species, as does the ability of MDMA to self-inhibit these enzymes and the degree of genetic polymorphisms exhibited by these enzymes. Such features limit allometric scaling across animal models.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15380932     DOI: 10.1016/j.tips.2004.08.001

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  54 in total

1.  Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings.

Authors:  Mariana Cherner; Chad Bousman; Ian Everall; Daniel Barron; Scott Letendre; Florin Vaida; J Hampton Atkinson; Robert Heaton; Igor Grant
Journal:  J Int Neuropsychol Soc       Date:  2010-08-23       Impact factor: 2.892

2.  Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differences.

Authors:  Melanie Mueller; Amy K Goodwin; Nancy A Ator; Una D McCann; George A Ricaurte
Journal:  J Pharmacol Exp Ther       Date:  2011-04-14       Impact factor: 4.030

3.  (+/-)-3,4-Methylenedioxymethamphetamine treatment in adult rats impairs path integration learning: a comparison of single vs once per week treatment for 5 weeks.

Authors:  Matthew R Skelton; Jessica A Able; Curtis E Grace; Nicole R Herring; Tori L Schaefer; Gary A Gudelsky; Charles V Vorhees; Michael T Williams
Journal:  Neuropharmacology       Date:  2008-07-12       Impact factor: 5.250

4.  MDMA: on the translation from rodent to human dosing.

Authors:  A Richard Green; Johan Gabrielsson; Charles A Marsden; Kevin C F Fone
Journal:  Psychopharmacology (Berl)       Date:  2009-01-13       Impact factor: 4.530

5.  Comment on the letter by Green, Gabrielsson, Marsden, and Fone, MDMA: on the translation from rodent to human dosing.

Authors:  Rafael de la Torre; Elena Puerta; Norberto Aguirre
Journal:  Psychopharmacology (Berl)       Date:  2009-01-16       Impact factor: 4.530

6.  Direct influence of serotonin on the larval heart of Drosophila melanogaster.

Authors:  Sameera Dasari; Robin L Cooper
Journal:  J Comp Physiol B       Date:  2005-12-14       Impact factor: 2.200

7.  (+)-Methamphetamine increases corticosterone in plasma and BDNF in brain more than forced swim or isolation in neonatal rats.

Authors:  Curtis E Grace; Tori L Schaefer; Nicole R Herring; Matthew R Skelton; Anne E McCrea; Charles V Vorhees; Michael T Williams
Journal:  Synapse       Date:  2008-02       Impact factor: 2.562

8.  Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats.

Authors:  Charles W Schindler; Eric B Thorndike; Bruce E Blough; Srihari R Tella; Steven R Goldberg; Michael H Baumann
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

9.  Age-dependent effects of neonatal methamphetamine exposure on spatial learning.

Authors:  Charles V Vorhees; Matthew R Skelton; Michael T Williams
Journal:  Behav Pharmacol       Date:  2007-09       Impact factor: 2.293

10.  Hydrolysis of 3,4-methylenedioxymethamphetamine (MDMA) metabolite conjugates in human, squirrel monkey, and rat plasma.

Authors:  Melanie Mueller; Erin A Kolbrich-Spargo; Frank T Peters; Marilyn A Huestis; George A Ricaurte; Hans H Maurer
Journal:  Anal Bioanal Chem       Date:  2009-01-30       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.